Susan Hasty, Publisher
Table of Contents . . . November 26th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Syphilis - Treponema pallidum repeat protein K antibodies protect against syphilis
Vaccine Delivery - Particle-mediated method for delivery of vaccines into epidermis developed
Cancer Vaccine - Converting tumors to Ii protein-negative phenotype causes tumor shrinkage
HIV/AIDS Vaccine - New gene-based approaches for AIDS vaccine reviewed
Prion Disease - Prion protein-derived peptide prolongs survival of mice exposed to scrapie
Vector Development - Poxviruses show promise as vaccine vectors
AIDS Therapy - Human trial of HIV vaccine in South Africa under way
Awards - NewsRx wins 2003 eHealthcare Leadership awards
Biowarfare - Prevention and treatment of bacterial bioterrorism agent diseases reviewed
Breast Cancer - Collaborative agreement set to develop new breast cancer vaccine
Cancer Immunotherapy - Company moves towards clinical trials with TAP cancer vaccine
Childhood Immunization - Infants held during immunization shots cry less
Childhood Immunization - Study eyes kids' problems, mercury link
Dengue Virus - Altered recombinant dengue virus 2 E protein blocks viral infectivity in vitro
Finance - Cancer vaccine company announces IPO of common stock
Finance - FluINsure maker announces closing of US$100 million bought deal financing
Finance - Smallpox vaccine maker gives clinical update, reports DKK 414.3M in revenue
Herpesvirus Vaccine - Chimeric Dr fimbriae with HSV epitope used as model for recombinant vaccine
Immunogenicity - Therapeutic biologicals must be developed without unwanted immunogenicity
Influenza Vaccine - Oculorespiratory syndrome occurs in up to 33% after influenza vaccination
Measles - Major U.K. outbreaks predicted if MMR vaccine does not increase
Mousepox - Team creates vaccine-evading virus
Poliovirus - Serial recombination found in type 1 wild-vaccine recombinant polioviruses
Prion Disease - Developments bringing prion diseases closer to therapy and prophylaxis
SARS - WHO says vaccine will take 2 years
Salmonella - Biological options for control of salmonella in poultry reviewed
Tuberculosis Vaccine - IL-15 increases efficacy of bacillus Calmette-Guerin vaccination
Vaccine Development - New approaches in vaccine development reviewed
Vaccine Efficacy - Preparing active patients for international travel
Vaccine Safety - Oculorespiratory syndrome linked to influenza vaccination
Vaccine Safety - Recommended immunization of patients with bleeding disorders outlined
Whooping Cough - Outbreaks reported in Alaska communities
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.